tirzepatide or semaglutide reddit A new study conducted by leading researchers across the United States suggests GLP-1s could have a much greater impact beyond obesity. Follow the link in our bio for more on the study Retatrutide for weight loss: Study

Gastrointestinal Applications The peptides strong association with digestive system research has made it a cornerstone compound in studies involving intestinal tissues, mucosal barriers, and gastrointestinal integrity

Retatrutide Weight Loss Results by Dose Weight loss was strongly dose-dependent

The comparison is most relevant - and most favorable to Direct Meds - for the cash-pay patient segment that represents the majority of GLP-1 seekers in the current market

The thermogenic and fat-oxidation benefits from glucagon receptor activation take 23 weeks to become noticeable

Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes

In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)